Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

A four-legged precedent for generic user fees

Executive Summary

Discussions between FDA and the Generic Pharmaceutical Association about the creation of a user fee program are on hold, but some generic drug companies are moving forward with another such program - this one for animal products. Led by Ivax's animal health division, the Generic Animal Drug Association has worked out a plan with the administration to add a generic component to the renewal of the animal drug user fee program now working its way through Congress. Whether the program will serve as a guide dog or a canary in the coal mine for the human generic industry remains to be seen
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS049709

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel